James Emmett Young insider trades
Open-market stock purchases and sales by James Emmett Young, Chief Financial Officer at TriSalus Life Sciences, Inc, from SEC Form 4 filings since Jan 27, 2025.
Track record: 0% of 2 scored buys are up 5% or more since purchase, averaging -42%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- TLSI TriSalus Life Sciences, Inc: 2 buys, last May 19, 2025